Literature DB >> 8386677

Ligand binding properties of human cellular retinoic acid binding protein II expressed in E. coli as a glutathione-S-transferase fusion protein.

C P Redfern1, K E Wilson.   

Abstract

To test the hypothesis that 9-cis-retinoic acid is a ligand for cellular retinoic acid binding protein II (CRABP II), human CRABP II was expressed as a glutathione-S-transferase fusion protein (GST-CRABP II) and a single affinity purification step used to extract it from bacterial lysates. GST-CRABP II bound all trans-retinoic acid with high affinity (Kd 14.2 +/- 6.5 nM), but 9-cis-retinoic acid bound poorly. These studies suggest that 9-cis-retinoic acid is not a ligand for CRABP II. Their ease of purification makes GST-CRABP fusion proteins useful tools for ligand binding studies with different retinoids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386677     DOI: 10.1016/0014-5793(93)80100-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  9-cis retinoic acid--a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma.

Authors:  P E Lovat; H Irving; A J Malcolm; A D Pearson; C P Redfern
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  Differential effects of 9-cis and all-trans retinoic acid on the induction of retinoic acid receptor-beta and cellular retinoic acid-binding protein II in human neuroblastoma cells.

Authors:  C P Redfern; P E Lovat; A J Malcolm; A D Pearson
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

3.  Novel Fluorescence Competition Assay for Retinoic Acid Binding Proteins.

Authors:  Charles W E Tomlinson; David R Chisholm; Roy Valentine; Andrew Whiting; Ehmke Pohl
Journal:  ACS Med Chem Lett       Date:  2018-11-09       Impact factor: 4.345

4.  A circularly permuted recombinant interleukin 4 toxin with increased activity.

Authors:  R J Kreitman; R K Puri; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 12.779

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.